Sleeping sickness parasite reveals enzyme weak spot that could guide safer drugs

African sleeping sickness and related diseases can be treated only with toxic and sometimes ineffective drugs. Now, University of Connecticut researchers show in Nucleic Acids Research that a crucial enzyme could be the key to safer, more effective medicines.

Originally published at Phys.org